ATE113472T1 - Affinitätsassoziierter impfstoff. - Google Patents

Affinitätsassoziierter impfstoff.

Info

Publication number
ATE113472T1
ATE113472T1 AT89402344T AT89402344T ATE113472T1 AT E113472 T1 ATE113472 T1 AT E113472T1 AT 89402344 T AT89402344 T AT 89402344T AT 89402344 T AT89402344 T AT 89402344T AT E113472 T1 ATE113472 T1 AT E113472T1
Authority
AT
Austria
Prior art keywords
vaccine
affinity
disclosed
associated vaccine
infective agent
Prior art date
Application number
AT89402344T
Other languages
English (en)
Inventor
Mircea C Popescu
Marie S Recine
Carl L Alving
Leonard F Estis
Lynn D Keyes
Andrew S Janoff
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ATE113472T1 publication Critical patent/ATE113472T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R13/00—Details of coupling devices of the kinds covered by groups H01R12/70 or H01R24/00 - H01R33/00
    • H01R13/46—Bases; Cases
    • H01R13/52—Dustproof, splashproof, drip-proof, waterproof, or flameproof cases
    • H01R13/5202—Sealing means between parts of housing or between housing part and a wall, e.g. sealing rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89402344T 1988-08-25 1989-08-25 Affinitätsassoziierter impfstoff. ATE113472T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23670188A 1988-08-25 1988-08-25
US23670288A 1988-08-25 1988-08-25
US39775889A 1989-08-23 1989-08-23

Publications (1)

Publication Number Publication Date
ATE113472T1 true ATE113472T1 (de) 1994-11-15

Family

ID=27398904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89402344T ATE113472T1 (de) 1988-08-25 1989-08-25 Affinitätsassoziierter impfstoff.

Country Status (6)

Country Link
EP (1) EP0356340B1 (de)
AT (1) ATE113472T1 (de)
DE (1) DE68919173T2 (de)
ES (1) ES2063154T3 (de)
GR (1) GR3014900T3 (de)
NZ (1) NZ230424A (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1093255A (zh) 1986-06-17 1994-10-12 恩特雷麦德有限公司 抗甾醇疫苗
JPH0334920A (ja) * 1989-04-21 1991-02-14 Otsuka Pharmaceut Co Ltd リポソームに結合及至組合わされた生物活性化合物及びそれを含有する医薬
NL9000207A (de) * 1990-01-29 1991-08-16 Duphar Int Res
IL97985A0 (en) * 1990-05-07 1992-06-21 North American Vaccine Inc Improved vaccine compositions
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
AU666473B2 (en) * 1990-12-10 1996-02-15 Entremed, Inc A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
WO1994016061A1 (en) * 1993-01-15 1994-07-21 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
ES2145132T3 (es) * 1993-02-26 2000-07-01 Fountain Pharm Inc Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.
WO1995016437A1 (en) * 1993-12-17 1995-06-22 Micro-Pak, Inc. Method of transmitting a biologically active material to a cell
DE69533693T2 (de) * 1994-02-24 2005-12-22 Novavax Inc.(n.d.Ges.d.Staates Delaware) Impfstoffe, die paucilamelläre Lipidvesikel als Adjuvans enthalten
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
GB0318096D0 (en) 2003-08-01 2003-09-03 Queen Mary & Westfield College Vaccine
EP1550458A1 (de) * 2003-12-23 2005-07-06 Vectron Therapeutics AG Synergisitische liposomale Adjuvantien
GB0426481D0 (en) 2004-12-02 2005-01-05 Vaccine Technology Ltd Composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148876A (en) * 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
US4891208A (en) * 1985-04-10 1990-01-02 The Liposome Company, Inc. Steroidal liposomes

Also Published As

Publication number Publication date
EP0356340B1 (de) 1994-11-02
DE68919173D1 (de) 1994-12-08
DE68919173T2 (de) 1995-03-09
GR3014900T3 (en) 1995-05-31
ES2063154T3 (es) 1995-01-01
EP0356340A1 (de) 1990-02-28
NZ230424A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
ATE113472T1 (de) Affinitätsassoziierter impfstoff.
FI903721A7 (fi) Uusia antigeenejä ja niihin liittyviä menetelmiä
DE58904696D1 (de) Ringfoermiger federkoerper aus faserverbundwerkstoffen.
DE3789761D1 (de) Reibungsmaterialien und Herstellung derselben.
DE58906025D1 (de) Klimaanlage.
FI872663L (fi) Menetelmä tahkoavan aineen tuottamiseksi ja menetelmällä tuotettu tahkoava keraaminen aine
NO904877D0 (no) Fremgangsmaate for fremstilling av titandioxyd.
NO895176D0 (no) Fremgangsmaate ved fremstilling av mono-n-alkylerte polyazamakrocykler.
DE68909152D1 (de) Druckluftventil und Trennvorrichtung.
DE68917740D1 (de) Klimaanlage.
FI894124A0 (fi) Fluorsubstituerade epipodofyllotoxinglukosider.
NO931798D0 (no) Fremgangsmaate for fremstilling av et alkalimetallklorat, samt en innretning for gjennomfoering av fremgangsmaaten
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
IT8723085A0 (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse.
DE68921134D1 (de) Herstellung von Organosilanen.
DE68922889D1 (de) Bildaufzeichnungsverfahren und Material.
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
KR900700426A (ko) 지방족 1,2-디올의 탈수소화 방법
KR890700355A (ko) 단백질-함유 항원의 부분양이온화와 면역화 및 탈감작법.
FR2665680B2 (fr) Hydroptere a coussin d'air ameliore.
PT89996A (pt) Processo para a preparacao de 3-(2,3,4,5,6-pentafluorofenoxi)-8-azabiciclo{3.2.1}octanos
FI944314A0 (fi) Vasta-aineen immunogeenisyyden selektiivinen muuttaminen
NO871805L (no) Herdbart lateksmateriale, samt fremgangsmaate for fremstilling av et slikt.
NO891941L (no) Fremgangsmaate for fremstilling av cycloalkadiener.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee